Comparative Pharmacology
Head-to-head clinical analysis: FLUCONAZOLE versus GYNE LOTRIMIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLUCONAZOLE versus GYNE LOTRIMIN.
Fluconazole vs GYNE-LOTRIMIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluconazole is a triazole antifungal agent that inhibits fungal cytochrome P450 14α-demethylase, thereby blocking the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane.
Clotrimazole, an imidazole antifungal, inhibits fungal cytochrome P450 14α-demethylase, thereby blocking the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane. This disrupts membrane integrity and function, leading to fungal cell death.
200-400 mg orally or intravenously once daily. For candidemia and other invasive Candida infections, loading dose of 800 mg (12 mg/kg) on day 1, then 400 mg (6 mg/kg) daily.
Intravaginal: clotrimazole 500 mg vaginal tablet once or 200 mg vaginal tablet daily for 3 days or 1% vaginal cream 5 g daily for 7–14 days. Topical: clotrimazole 1% cream applied to affected area twice daily for 2–4 weeks.
None Documented
None Documented
Clinical Note
moderateMethoxsalen + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Methoxsalen."
Clinical Note
moderateCyclophosphamide + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Cyclophosphamide."
Clinical Note
moderatePaclitaxel + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Paclitaxel."
Clinical Note
moderateDocetaxel + Fluconazole
Terminal elimination half-life ~30 hours (range 20-50 h) in patients with normal renal function; prolonged in renal impairment (up to 98 h in CrCl <20 mL/min). This long half-life supports once-daily dosing and allows loading dose administration.
The terminal elimination half-life of clotrimazole is approximately 3.5-4.9 hours. However, after topical application, systemic absorption is minimal, and local concentrations persist for hours to days at the site of action.
Renal: approximately 80% as unchanged drug; biliary/fecal: ~11% as metabolites and unchanged drug.
Primarily fecal (approx. 90%) as unchanged drug and metabolites; renal excretion accounts for <1% of absorbed dose.
Category C
Category C
Azole Antifungal
Azole Antifungal
"The metabolism of Fluconazole can be decreased when combined with Docetaxel."